10-Year Impact on Productivity Costs Associated with Mortality in Stage III or IV Classical Hodgkin Lymphoma Based on the Overall Survival Update of the ECHELON-1 Trial: Application of an Oncology Simulation Model in the United States
Blood (2022) 140 (Supplement 1): 10791–10792.
Currently there are no citedby results. Try again later.
